Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. Gut 2023 Dec 07;73(1):16-46

Date

09/29/2023

Pubmed ID

37770126

Pubmed Central ID

PMC10715509

DOI

10.1136/gutjnl-2023-330029

Scopus ID

2-s2.0-85173470567 (requires institutional sign-in at Scopus site)   4 Citations

Abstract

These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included a multidisciplinary team of experts from various specialties involved in the management of CCA, as well as patient/public representatives from AMMF (the Cholangiocarcinoma Charity) and PSC Support. Quality of evidence is presented using the Appraisal of Guidelines for Research and Evaluation (AGREE II) format. The recommendations arising are to be used as guidance rather than as a strict protocol-based reference, as the management of patients with CCA is often complex and always requires individual patient-centred considerations.

Author List

Rushbrook SM, Kendall TJ, Zen Y, Albazaz R, Manoharan P, Pereira SP, Sturgess R, Davidson BR, Malik HZ, Manas D, Heaton N, Prasad KR, Bridgewater J, Valle JW, Goody R, Hawkins M, Prentice W, Morement H, Walmsley M, Khan SA

Author

Kondragunta Rajendra Prasad MBBS Professor in the Surgery department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Bile Duct Neoplasms
Bile Ducts, Intrahepatic
Cholangiocarcinoma
Gastroenterology
Humans